Chemotherapy News and Research

Latest Chemotherapy News and Research

Checkpoint inhibitor for treatment of NSCLC patients shows indication of added benefit

Nivolumab has been approved since April 2016 as a checkpoint inhibitor for the treatment of adults with locally advanced or metastatic nonsquamous non-small-cell lung cancer (NSCLC) who have already undergone chemotherapy.

19 Aug 2016

Added benefit of lung cancer drug not proven, says IQWiG

Afatinib (trade name: Giotrif) has been approved since April 2016 for the treatment of adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) of squamous histology who have already received chemotherapy.

19 Aug 2016

Added benefit not proven for orphan drug in treatment of adults with stomach cancer

Ramucirumab (trade name: Cyramza) is a monoclonal antibody, which blocks a receptor, reducing the growth of blood vessels and so reducing blood supply to the tumours.

19 Aug 2016

New study reports long-lasting cognitive impairments in mice after chemotherapy treatment

Women undergoing chemotherapy for breast cancer have long complained of lingering cognitive impairments after treatment.

19 Aug 2016

Colorectal tumors present epigenetic heterogeneity, study finds

A new study led by Dr. Manel Esteller, Director of the Epigenetics and Cancer Biology Program of Bellvitge Biomedical Research Institute, ICREA researcher and Professor of Genetics at University of Barcelona discovers that colorectal tumors present epigenetic heterogeneity that relates to the clinical course of the disease.

18 Aug 2016

New NIST Standard Reference Material helps ensure accurate measurements of HER2 breast cancer gene

A new measurement standard developed by the National Institute of Standards of Technology has been used successfully by the Frederick National Laboratory for Cancer Research to check the performance of next-generation DNA-sequencing technologies for evaluating gene variations associated with an increased risk of breast cancer.

18 Aug 2016

Maintaining proper oxygen supply in tumors could be key factor to stop progression of cancer

The lack of oxygen in tumor cells changes the cells' gene expression, thereby contributing to the growth of cancer.

18 Aug 2016

MDI Biological Laboratory receives NIH grant for research on peripheral neuropathy

The MDI Biological Laboratory has announced that it has received a grant of $456,500 over two years from the National Institutes of Health for the study of peripheral neuropathy.

17 Aug 2016

Research article outlines utilization of calixarenes in biocatalysis and cancer therapy

Calixarenes bear a fascinating class of macrocycles that have served broadly in molecular recognition and supramolecular chemistry.

17 Aug 2016

Penicillin allergy testing: an interview with Dr. Eric Macy

Penicillin was one of the first antibiotics developed and has saved millions of lives. First used in the early 1940s, penicillin is still one of the most widely used and least toxic family of antibiotics.

17 Aug 2016

Study shows microRNA molecule prevents cancer cells from responding to chemotherapy treatment

Annually about 2000 Danish patients with colorectal cancer are treated with chemotherapy. Today, a range of different chemotherapeutic regimens are available. However, deciding which regimen to use is not easy.

16 Aug 2016

Researchers develop new nanorobotic agents to deliver drugs by targeting cancerous tumours

Researchers from Polytechnique Montréal, Université de Montréal and McGill University have just achieved a spectacular breakthrough in cancer research.

16 Aug 2016

Study shows leptomeningeal metastases more prevalent in NSCLC patients with EGFR mutations

Leptomeningeal metastases (LM), a devastating complication and predictor of poor survival in lung cancer patients, was found to be more prevalent in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations.

16 Aug 2016

Study explains long-term pulmonary outcomes among childhood cancer survivors

A team of researchers from nine leading academic hospitals and research centers have published a paper in the early online edition of the journal Cancer that describes pulmonary outcomes among childhood cancer survivors.

16 Aug 2016

SGO and ASCO release clinical practice guidelines on ovarian cancer treatment

This week the Society of Gynecologic Oncology and the American Society of Clinical Oncology issued a joint clinical practice guideline on ovarian cancer treatment.

12 Aug 2016

BCL-2 inhibitor shows promise in AML patients

Patients whose acute myelogenous leukemia (AML) had relapsed or was resistant to chemotherapy and those who were deemed unable to tolerate chemotherapy experienced responses to the selective BCL-2 inhibitor venetoclax (Venclexta), with complete remissions in some, according to phase II clinical trial data.

12 Aug 2016

Chemotherapy News and Research

Latest Chemotherapy News and Research

Checkpoint inhibitor for treatment of NSCLC patients shows indication of added benefit

Added benefit of lung cancer drug not proven, says IQWiG

Added benefit not proven for orphan drug in treatment of adults with stomach cancer

New study reports long-lasting cognitive impairments in mice after chemotherapy treatment

Colorectal tumors present epigenetic heterogeneity, study finds

New NIST Standard Reference Material helps ensure accurate measurements of HER2 breast cancer gene

Maintaining proper oxygen supply in tumors could be key factor to stop progression of cancer

MDI Biological Laboratory receives NIH grant for research on peripheral neuropathy

Research article outlines utilization of calixarenes in biocatalysis and cancer therapy

Penicillin allergy testing: an interview with Dr. Eric Macy

Study shows microRNA molecule prevents cancer cells from responding to chemotherapy treatment

Researchers develop new nanorobotic agents to deliver drugs by targeting cancerous tumours

Study shows leptomeningeal metastases more prevalent in NSCLC patients with EGFR mutations

Study explains long-term pulmonary outcomes among childhood cancer survivors

SGO and ASCO release clinical practice guidelines on ovarian cancer treatment

BCL-2 inhibitor shows promise in AML patients

Lancaster researchers develop new blood-testing technology to improve healthcare treatments

Researchers develop computational algorithm to analyze big genomic data for different cancers

Economic crisis linked to cancer mortality increase? An interview with Dr Mahiben Maruthappu

CTCA at Western begins clinical trial for novel antibody to treat patients with advanced tumors

Cancer Research - Second Edition eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in